← Back to Search

Mindfulness Meditation

Internet-Based Webinars for Chronic Myelogenous Leukemia

N/A
Waitlist Available
Led By Kelly Schoenbeck, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, and 8 weeks, up to 8 weeks total
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a mindfulness meditation program called 'Being Present' to help patients with certain types of leukemia and their caregivers reduce stress. The program includes online exercises and regular reminders to improve their quality of life by focusing on the present moment. The 'Being Present' program was previously tested for colorectal cancer patients and caregivers, showing potential in reducing distress and improving quality of life.

Eligible Conditions
  • Myeloproliferative Neoplasms
  • Chronic Myelogenous Leukemia
  • Leukemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, and 8 weeks, up to 8 weeks total
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks, and 8 weeks, up to 8 weeks total for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Duration of playing recorded webinars
Frequency of Attrition Causes
Frequency of Attrition over time
+11 more
Secondary study objectives
Malignant Neoplasms
Mean change in scores on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
Mean change in scores on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-CML24)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Being Present (Supportive Care)Experimental Treatment2 Interventions
Patients and caregivers receive Being Present intervention consisting of online audio-based mindfulness meditation exercise over 15 minutes at least 5 times per week, daily meditation reminders, and online webinars over 30-60 minutes every week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Online Mindfulness Meditation
2020
N/A
~120

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,588 Previous Clinical Trials
14,900,960 Total Patients Enrolled
American Society of HematologyOTHER
13 Previous Clinical Trials
20,978 Total Patients Enrolled
Kelly Schoenbeck, MDPrincipal InvestigatorUniversity of California, San Francisco
~9 spots leftby Dec 2025